腺癌
巨噬细胞移动抑制因子
肺癌
癌症研究
小RNA
免疫组织化学
癌症
病理
生物
阶段(地层学)
肿瘤科
医学
内科学
基因
遗传学
古生物学
细胞因子
作者
Akiteru Goto,Masamitsu Tanaka,Makoto Yoshida,Michinobu Umakoshi,Hiroshi Nanjo,Kouya Shiraishi,Motonobu Saito,Takashi Kohno,Sei Kuriyama,Hayato Konno,Kazuhiro Imai,Hajime Saito,Yoshihiro Minamiya,Daichi Maeda
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2017-07-12
卷期号:12 (7): e0181270-e0181270
被引量:44
标识
DOI:10.1371/journal.pone.0181270
摘要
This clinicopathological study of 370 NSCLC cases and the cell biological studies of NSCLC cell lines clarified the tumor-suppressive role of miR-451 and its prognostic value. We also validated MIF as a target of miR-451 in NSCLC.
科研通智能强力驱动
Strongly Powered by AbleSci AI